• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例罕见的多形红斑型粘菌素疹。

A rare case of Colistin induced maculopapular rash.

机构信息

Department of Pharmacy Practice, JSS College of Pharmacy, JSSAHER Mysuru, Karnataka, India.

出版信息

J Infect Dev Ctries. 2020 Aug 31;14(8):929-930. doi: 10.3855/jidc.12148.

DOI:10.3855/jidc.12148
PMID:32903239
Abstract

Approximately 2-3% of hospitalized patients are known to experience an adverse drug reaction (ADR). Dermatologic ADRs account for 10-30% of ADRs, and are commonly reported to be associated with antibiotic use. The classes of antibiotics most commonly reported to cause cutaneous reactions are the penicillins, cephalosporins, and fluoroquinolones. Polymyxin E is known to cause such reactions, but rarely. Here, we report a case of a colistin- induced maculopapular rash in an 84-year-old male. To the best of our knowledge, this is the first case of colistin-induced maculopapular rash to be reported in India.

摘要

据报道,约有 2-3%的住院患者会发生药物不良反应(ADR)。皮肤药物不良反应占 ADR 的 10-30%,通常与抗生素的使用有关。最常报告引起皮肤反应的抗生素类别是青霉素类、头孢菌素类和氟喹诺酮类。黏菌素 E 已知会引起此类反应,但很少见。在这里,我们报告了一例 84 岁男性因多粘菌素 E 引起的斑丘疹。据我们所知,这是印度首例多粘菌素 E 引起的斑丘疹病例。

相似文献

1
A rare case of Colistin induced maculopapular rash.一例罕见的多形红斑型粘菌素疹。
J Infect Dev Ctries. 2020 Aug 31;14(8):929-930. doi: 10.3855/jidc.12148.
2
Intravenous and inhalational colistin-induced respiratory failure.静脉注射和吸入性黏菌素引起的呼吸衰竭。
Clin Infect Dis. 2010 Mar 15;50(6):e38-40. doi: 10.1086/650582.
3
Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.耐黏菌素鲍曼不动杆菌分离株引起的菌血症:一例报告。
J Med Case Rep. 2019 May 8;13(1):141. doi: 10.1186/s13256-019-2062-3.
4
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.黏菌素(多黏菌素甲磺酸钠)治疗泰国曼谷诗里拉吉医院耐多药铜绿假单胞菌和鲍曼不动杆菌所致感染的疗效与安全性
Int J Infect Dis. 2007 Sep;11(5):402-6. doi: 10.1016/j.ijid.2006.09.011. Epub 2007 Feb 8.
5
Extensive drug resistant Acinetobacter baumannii: a comparative study between non-colistin based combinations.广泛耐药鲍曼不动杆菌:基于非黏菌素联合治疗方案的比较研究
Int J Clin Pharm. 2020 Feb;42(1):80-88. doi: 10.1007/s11096-019-00940-1. Epub 2019 Nov 19.
6
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin.持续静脉输注黏菌素治疗多重耐药鲍曼不动杆菌菌血症
Scand J Infect Dis. 2005;37(2):142-5. doi: 10.1080/00365540410020776.
7
Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.脑室内注射与静脉注射黏菌素治疗广泛耐药鲍曼不动杆菌脑膜炎的比较
Eur J Neurol. 2016 Jan;23(1):68-75. doi: 10.1111/ene.12789. Epub 2015 Jul 31.
8
Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis.多黏菌素单用或联合治疗成人鲍曼不动杆菌感染的安全性和有效性:系统评价和荟萃分析。
Int J Antimicrob Agents. 2019 Apr;53(4):383-400. doi: 10.1016/j.ijantimicag.2018.10.020. Epub 2018 Nov 14.
9
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.联合使用黏菌素和利福平治疗耐碳青霉烯类鲍曼不动杆菌感染:临床疗效和不良事件
Clin Microbiol Infect. 2005 Aug;11(8):682-3. doi: 10.1111/j.1469-0691.2005.01198.x.
10
High rate of colistin dependence in Acinetobacter baumannii.鲍曼不动杆菌中黏菌素依赖性的高发生率。
J Antimicrob Chemother. 2016 Aug;71(8):2346-8. doi: 10.1093/jac/dkw121. Epub 2016 Apr 13.